1. Home
  2. APM vs AIIOW Comparison

APM vs AIIOW Comparison

Compare APM & AIIOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • AIIOW
  • Stock Information
  • Founded
  • APM 2010
  • AIIOW N/A
  • Country
  • APM United Kingdom
  • AIIOW United Arab Emirates
  • Employees
  • APM N/A
  • AIIOW N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • AIIOW Auto Manufacturing
  • Sector
  • APM Health Care
  • AIIOW Industrials
  • Exchange
  • APM Nasdaq
  • AIIOW Nasdaq
  • Market Cap
  • APM 18.9M
  • AIIOW 19.0M
  • IPO Year
  • APM 2018
  • AIIOW N/A
  • Fundamental
  • Price
  • APM $1.96
  • AIIOW $0.05
  • Analyst Decision
  • APM
  • AIIOW
  • Analyst Count
  • APM 0
  • AIIOW 0
  • Target Price
  • APM N/A
  • AIIOW N/A
  • AVG Volume (30 Days)
  • APM 20.5M
  • AIIOW N/A
  • Earning Date
  • APM 04-30-2025
  • AIIOW N/A
  • Dividend Yield
  • APM N/A
  • AIIOW N/A
  • EPS Growth
  • APM N/A
  • AIIOW N/A
  • EPS
  • APM N/A
  • AIIOW N/A
  • Revenue
  • APM N/A
  • AIIOW N/A
  • Revenue This Year
  • APM N/A
  • AIIOW N/A
  • Revenue Next Year
  • APM N/A
  • AIIOW N/A
  • P/E Ratio
  • APM N/A
  • AIIOW N/A
  • Revenue Growth
  • APM N/A
  • AIIOW N/A
  • 52 Week Low
  • APM $0.46
  • AIIOW N/A
  • 52 Week High
  • APM $7.49
  • AIIOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • APM 52.30
  • AIIOW N/A
  • Support Level
  • APM $1.64
  • AIIOW N/A
  • Resistance Level
  • APM $2.65
  • AIIOW N/A
  • Average True Range (ATR)
  • APM 0.20
  • AIIOW 0.00
  • MACD
  • APM -0.04
  • AIIOW 0.00
  • Stochastic Oscillator
  • APM 31.68
  • AIIOW 0.00

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: